Shoulder injection of platelet-rich plasma versus corticosteroids in rotator cuff tendinopathies.
S Bouden, C Jebali, S Ben Dhia...
https://pubmed.ncbi.nlm.nih.gov/41848176/Actively Recruiting
Led by Hopital Charles Nicolle · Updated on 2025-07-30
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
Shoulder tendinopathy is a common condition causing pain and limiting daily activities due to damage or overuse of the rotator cuff tendons. Researchers are comparing two injection treatments for this condition corticosteroid injections, which reduce inflammation and provide quick pain relief but may have short-term effects, and Platelet-Rich Plasma PRP injections, made from the patients own blood, which may promote longer-term healing. This trial involves adult patients diagnosed with simple shoulder tendinopathy confirmed by clinical examination and imaging. The study randomly assigns 60 adult participants to receive either a single corticosteroid injection or a single PRP injection into the affected shoulder tendon. Corticosteroid injections aim to quickly reduce pain and inflammation, while PRP injections focus on promoting tissue healing and longer-term recovery. Both injections are given under sterile conditions by trained physicians. Patients will be monitored for changes in pain and shoulder function at one week and three months after the injection. Participants will undergo evaluations before the injection and at follow-up visits one week and three months later. Pain levels will be measured using a visual analog scale VAS, and shoulder function will be assessed with the Disabilities of the Arm, Shoulder and Hand DASH score and the Shoulder Pain and Disability Index SPADI. These assessments will help determine which treatment provides better pain relief and functional improvement over time. The study is conducted at the Rheumatology Department of Charles Nicolle Hospital in Tunis, Tunisia, with a total participation duration of about three months post-injection.
CONDITIONS
Corticosteroid Versus PRP Injections for Shoulder Tendinopathy
S
Selma Bouden, Assistant doctor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hopital Charles Nicolle
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single administration with follow-up to 3 months
Participants receive a single injection of either corticosteroids or platelet-rich plasma into the affected shoulder tendon to reduce pain and improve function.
1 treatment visit and 2 follow-up visits at 1 week and 3 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
S Bouden, C Jebali, S Ben Dhia...
https://pubmed.ncbi.nlm.nih.gov/41848176/Hopital Charles Nicolle
Lead Sponsor